LETTERS for the December 12 issue
Suggestions for the West Maui Community Plan
I have attended some of the West Maui CPAC meetings and could not get this answered when I was there.
There was the Kaanapali 2020 Plan, Puukolii Village Mauka Plan and the Kaanapali Coffee Farms Plan that were professional and well-thought-out by Kaanapali Land Management Corp.
They covered parks, schools, medical services, assisted living facilities, housing, affordable housing and transportation.
Maps and drawings were prepared and laid everything out. They were well prepared.
Now it seems we are trying to do what has already been done with the West Maui CPAC meetings.
Money was spent on the plans noted above, and now the county is spending more time and money with the Maui CPAC Plan.
Instead of re-doing plans and spending money to do so, why doesn’t the county just approve and execute, with the developers, the Kaanapali 2020 Plan and Puukolii Village Mauka Plan, as well as finish the Kaanapali Coffee Farms development?
Honoapiilani Highway is a disaster waiting to happen. That is what really should be addressed first.
West Maui cannot afford to be cut off from the rest of the island due to an inadequate highway. Coastal erosion is evident in many places along the current highway. Road delays are a common occurrence.
I hope we never have to face the delay/isolation that a major storm, quake or tsunami could cause.
DOUG KELLY, Maui Resident
Keep Handicap Parking open
Don’t know what the Handicap Parking laws are? Who’s in charge and who’s responsible?
I was told the fine is $500 for illegal parking. I’ve seen and heard people say, “Oh, I forgot my placard at home (NO handicap plates). I’m just gonna run in to get something quick! It won’t take long.”
When non-handicapped people park part of their cars in the handicap zone, I can’t get my wheelchair out.
Where’s the respect for those who are handicapped?
I hope the police and security guards of stores/shopping malls take responsibility… STEP UP!
Do the right thing (PONO). It may be you or one of your loved ones.
All who adhere to the laws, THANK YOU. To those who are NOT, DON’T MAKE POOR EXCUSES!
Happy Holidays to most of the considerate people who think about those who are disabled.
NAME WITHHELD BY REQUEST
Progress will result from injection well lawsuit
(The following letter was sent to state and county officials.)
The letter to the editor from Linda Lyerly of Kahana stated: “The mayor could still settle the case by simply withdrawing it from the courts.”
This seems to be out of context of what is really happening in this case.
We support the idea that when a wrong has been done, to learn from that wrong involved penalties – “POWER OF THE TAXPAYER.”
Learning is progress, even at the cost to the Maui County taxpayer.
By doing so, we believe that better technology systems will be designed and put into place.
LEO THINER-BRICKEY, Honokowai
Senate’s proposed drug plan brings death and taxes
The Prescription Drug Pricing Reduction Act would stall future drug development and deprive Americans of lifesaving cures – all without reducing patients’ out-of-pocket costs.
The bill would alter Medicare Part D, the federal prescription drug benefit for seniors and people with disabilities. Today, 45 million Americans receive drug coverage from Part D.
Part D is a free market success story. Instead of administering the benefit directly, Uncle Sam subsidizes private insurers who sell plans to beneficiaries.
Since these insurers compete for customers, they have every incentive to keep costs low. Part D cost nearly $350 billion less over its first ten years than originally estimated.
Unfortunately, the Prescription Drug Pricing Reduction Act would upend this tried-and true-structure. The bill’s most egregious penalty might be the 20 percent tax it would impose on manufacturers for some drugs sold in Part D. The package would cost biopharmaceutical firms $55 billion over the next ten years.
This massive tax would save the government money, but it wouldn’t do much for patients – 98 percent of Medicare beneficiaries won’t see a reduction in their pharmacy bills. Some could even face increased out-of-pocket costs.
Over time, this bill would harm patients by making it harder to fund drug research. It takes $2.6 billion on average for researchers to bring one new treatment to market. Scientists rely on the revenue from successful drugs to fund future research projects.
The myriad taxes in the bill would impede manufacturers’ ability to earn back development costs. That would make it difficult for firms to attract the investment they need to research new treatments.
Without that funding, scientists would have to abandon the roughly 4,500 drugs currently being developed for cancer, Alzheimer’s and other diseases in the United States.
The package wouldn’t just hurt patients. The pharmaceutical sector supports close to five million jobs and contributes more than $1 trillion in economic output each year.
Nearly half of drug firms said that reductions in R&D could lead to layoffs and facility closures.
The Prescription Drug Pricing Reduction Act would cripple the life sciences sector and do nothing to help patients afford their medicines.
Talk about a lose-lose!